跳至主要内容
临床试验/DRKS00034189
DRKS00034189招募中不适用

Analysis of Disease Modulation by Immunoglobulin Replacement in patients with variable immunodeficiency syndrome (CVID) - ADMIRE

niversitätsklinikum Freiburg0 个研究点目标入组 10 人开始时间: 2024年5月2日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1. Diagnosis of CVID according to ESID/PAGID criteria or diagnosis of related disorders which fulfill the diagnostic criteria for CVID.
  • 2. Patients with the need for IgGRT according to standard guidelines.
  • 3. Patients who received an initial intravenous IgG replacement therapy (IVIG)
  • 4. Signed written informed consent

排除标准

  • 1. Immunosuppressive therapy beyond 7.5 mg prednisone equivalent/day during the observation period, including biologicals
  • 2. Patients on IgGRT within the last two years before collection of baseline data
  • 3. Lymphoma or other form of malignancy within the past 5 years before collection of baseline data

研究者

相似试验